TL;DR
This study investigates the link between Lp-PLA2 mass, a marker of inflammation, and asymptomatic cerebral artery stenosis (ACAS) in a Chinese population. They found that higher Lp-PLA2 levels are associated with an increased risk of ACAS, particularly in men and older individuals, suggesting Lp-PLA2 could be a useful biomarker for early detection of stroke risk.
What Problem Does This Paper Address?
Ischemic stroke is a major cause of death and disability worldwide, and cerebral artery stenosis (CAS) is a significant contributor. Identifying individuals at risk for stroke, especially those with asymptomatic stenosis, is crucial for timely intervention. While lipoprotein-associated phospholipase A2 (Lp-PLA2) has been implicated in atherosclerosis, its role in asymptomatic cerebral artery stenosis has been inconsistent across studies, possibly due to differing populations and methodologies. This paper aims to clarify this association in a large cohort of asymptomatic North Chinese adults, exploring Lp-PLA2 as a potential biomarker for early detection of subclinical cerebrovascular disease.
Methods
This was a cross-sectional study involving 2012 North Chinese adults aged 40 and above. Serum Lp-PLA2 mass was measured using enzyme-linked immunosorbent assay (ELISA). Cerebral artery stenosis was assessed using two primary methods: transcranial Doppler (TCD) for intracranial artery stenosis (ICAS) and bilateral carotid duplex ultrasound for extracranial arterial stenosis (ECAS). Asymptomatic cerebral artery stenosis (ACAS) was defined as the presence of at least one of these stenoses. Statistical analyses, including logistic regression, were used to determine the association between Lp-PLA2 mass quartiles and the presence of ACAS, ICAS, and ECAS, while controlling for various vascular risk factors.
Datasets
The study utilized data from the Asymptomatic Polyvascular Abnormalities in Community (APAC) study, which included a random sample of 5440 participants aged ≥40 years from the Kailuan Study population. For this specific analysis, 2012 participants with complete demographic and blood sample information were selected. No new datasets were introduced.
Key Insights and Ideas
- Lp-PLA2 as a potential early warning sign: The study strongly suggests that elevated Lp-PLA2 mass is not just associated with existing cardiovascular issues but can be an indicator of silent, developing problems like asymptomatic cerebral artery stenosis.
- Sex and age matter: The association between Lp-PLA2 and ACAS was significantly stronger in men and older individuals. This highlights potential sex-specific or age-related differences in how Lp-PLA2 contributes to atherosclerosis.
- Beyond inflammation: While Lp-PLA2 is known as an inflammatory marker, its consistent association with stenosis across different types (intracranial and extracranial) points to a broader role in the atherosclerotic process.
- Biomarker potential: The findings support the idea that Lp-PLA2 mass could be a valuable, non-invasive tool to identify individuals who might be at higher risk for stroke, even before symptoms appear.
Key Results
The study found that participants in the highest quartile of Lp-PLA2 mass had a significantly increased risk of asymptomatic cerebral artery stenosis (ACAS). Specifically, the adjusted odds ratio (OR) for ACAS in the 4th quartile compared to the 1st quartile was 1.98 (95% CI: 1.42-2.78). This association remained significant for both intracranial (ICAS) and extracranial (ECAS) stenoses. The association was particularly pronounced in males (OR = 2.00) and older participants (aged ≥60 years, OR = 2.76 for ACAS in the highest quartile compared to the lowest, after stratification).
Limitations and Future Work
The authors acknowledge several limitations:
- Diagnostic method: The reliance on TCD for ICAS diagnosis, rather than the gold standard of conventional angiography, might have included patients with non-atherosclerotic vascular pathology.
- Sample storage: Blood samples were stored for 3-4 years at -80°C, which, while generally considered acceptable for Lp-PLA2 stability, could introduce some variability.
- Cross-sectional design: This design limits the ability to establish a definitive cause-and-effect relationship between Lp-PLA2 mass and ACAS.
- Study population: The majority of participants were coal workers, which may limit the generalizability of the findings to other populations.
Future work could involve longitudinal studies to confirm the predictive value of Lp-PLA2 for stroke events in individuals with ACAS. Further research is also needed to elucidate the sex-specific mechanisms underlying the observed associations and to explore the role of Lp-PLA2 in middle-aged populations.
Summary updated